Homepage / The European Pharmacopoeia / European Pharmacopoeia / Background & Legal Framework

The European Pharmacopoeia is a single reference work for the quality control of medicines in the signatory states of the Convention on its elaboration.
The official standards published within provide a legal and scientific basis for quality control during the development, production and marketing processes.
They concern the qualitative and quantitative composition and the tests to be carried out on medicines, on the raw materials used in production of medicines and on the intermediates of synthesis. All producers of medicines and/or substances for pharmaceutical use must therefore apply these quality standards in order to market their products in the signatory states of the Convention.
Several legal texts make the European Pharmacopoeia mandatory. These are as follows:
The contracting parties of the Convention undertake to:
For information about the working procedure and the functions of the different bodies responsible for carrying out the work of elaborating a European Pharmacopoeia, please consult the documents in the right-hand menu.
143rd Session, 19-20 June 2012
144th Session, 27-28 November 2012
Guide for the Work of the European Pharmacopoeia (PA/PH/SG (10) 42 DEF)
Rules of Procedure of the European Pharmacopoeia Commission (PA/PH/SG (07) 4 DEF)
Code of Practice for the work of the European Pharmacopoeia (PA/PH/Exp. ROP/T (07) 1 DEF)
List of Groups of Experts & Working Parties
European Commission - Directorate General Health & Consumer Protection (DG Sanco)
7 allée Kastner, CS 30026, F67081 Strasbourg, France - Tel. +33 (0)3 88 41 30 30 - Fax +33 (0)3 88 41 27 71
Created by 2exVia with MasterEdit®